API INTERMEDIATES

INTERMEDIATES OF Lenvatinib

Below is a list of Lenvatinib intermediates that we currently offer. Click on the name of each intermediate to access detailed information specific to your requirements.

If you cannot find the specific Lenvatinib intermediate you are looking for on this page, please submit a sourcing request by providing the intermediate's CAS No. and name. Our team will promptly respond with further details. To make a request, please click here to send an email.

For any inquiries about upstream or downstream intermediates related to your Lenvatinib requirements, please feel free to reach out. Based on your specifications, we can help source a reliable manufacturer, supplier, or principal who meets the quality standards you require.

S. NoProduct NameCAS No.Product DetailsQuote
1Meldrum's acid2033-24-1View

Send us your Intermediates inquiries to bdteam@sspharma.com

Terms and Conditions: Intellectual Property and Regulatory Compliance

Terms and Conditions: Intellectual Property and Regulatory Compliance

  • Buyer’s Responsibility:
    Buyers are responsible for ensuring that the goods they procure and use do not knowingly infringe upon intellectual property rights, including patents, of any party.
  • Seller’s Responsibility:
    Sellers must refrain from offering goods that violate intellectual property rights, including patents, of any party.
  • Research and Development Use Only:
    Products protected under active U.S. patents are provided exclusively for research and development purposes, as outlined in 35 USC 271 +A13(1).
  • Export of Controlled Substances:
    Controlled substances or scheduled drugs are exported solely by the authorized entities of the manufacturer. Such exports require an original import permit from the appropriate regulatory authorities in the receiving country.
  • Patent Compliance:
    Products covered by active patents will not be offered for sale in regions where such sales would violate patent laws. Buyers are fully responsible for any liabilities resulting from non-compliance with patent regulations.
  • Policy on Inquiries:
    SS Pharma Group strictly responds only to inquiries submitted with verifiable contact details. Anonymous or pseudonymous inquiries will not be entertained.
  • Liability Disclaimer:
    SS Pharma Group is not liable for any purchases or usage of products that infringe on intellectual property rights, including patents, of any party. No warranties, whether express or implied, are provided regarding the originality, authenticity, or compliance of products with intellectual property laws.

This website is maintained and regularly updated by SS Pharma Group to ensure transparency and compliance.

Under Development

S#Product NameTherapeutic AreaQUOTE
1BrivaracetamAnticonvulsant
2Bempedoic AcidAnticoagulant
3Esomeprazole Gastro-Intestinal
4LevetiracetamAnticonvulsant
5RanolazineAnticoagulant
6Ropinirole HydrochlorideAntiparkinson
7Rosuvastatin CalciumAntilipidemic
8SulindacAnti-Inflammatory
9TicagrelorAnticoagulant
10Varenicline Tartrate Anti-Smoking
Close Menu